SLC5A7 and colorectal carcinoma: This study elucidates the mechanism by which circFBXW4 inhibits the progression of CRC by the miR‐338‐5p/SLC5A7 axis and not only provides new insights into the pathogenesis of CRC but also identifies a potential therapeutic target for CRC.